Titre : Facteurs de transcription EGR

Facteurs de transcription EGR : Questions médicales fréquentes

Termes MeSH sélectionnés :

Implementation Science
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Facteurs de transcription EGR : Questions médicales les plus fréquentes", "headline": "Facteurs de transcription EGR : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Facteurs de transcription EGR : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-08", "dateModified": "2025-05-03", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Facteurs de transcription EGR" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Facteurs de transcription", "url": "https://questionsmedicales.fr/mesh/D014157", "about": { "@type": "MedicalCondition", "name": "Facteurs de transcription", "code": { "@type": "MedicalCode", "code": "D014157", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.930" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Facteur de transcription EGR-1", "alternateName": "Early Growth Response Protein 1", "url": "https://questionsmedicales.fr/mesh/D051766", "about": { "@type": "MedicalCondition", "name": "Facteur de transcription EGR-1", "code": { "@type": "MedicalCode", "code": "D051766", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.930.213.500" } } }, { "@type": "MedicalWebPage", "name": "Facteur de transcription EGR-2", "alternateName": "Early Growth Response Protein 2", "url": "https://questionsmedicales.fr/mesh/D051767", "about": { "@type": "MedicalCondition", "name": "Facteur de transcription EGR-2", "code": { "@type": "MedicalCode", "code": "D051767", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.930.213.750" } } }, { "@type": "MedicalWebPage", "name": "Facteur de transcription EGR-3", "alternateName": "Early Growth Response Protein 3", "url": "https://questionsmedicales.fr/mesh/D051776", "about": { "@type": "MedicalCondition", "name": "Facteur de transcription EGR-3", "code": { "@type": "MedicalCode", "code": "D051776", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.930.213.875" } } } ], "about": { "@type": "MedicalCondition", "name": "Facteurs de transcription EGR", "alternateName": "Early Growth Response Transcription Factors", "code": { "@type": "MedicalCode", "code": "D051765", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "John P Lydon", "url": "https://questionsmedicales.fr/author/John%20P%20Lydon", "affiliation": { "@type": "Organization", "name": "Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA." } }, { "@type": "Person", "name": "Elizabeth Jose", "url": "https://questionsmedicales.fr/author/Elizabeth%20Jose", "affiliation": { "@type": "Organization", "name": "Molecular and Cellular Biology, University of Arizona, Tucson, AZ, 85721." } }, { "@type": "Person", "name": "Woody March-Steinman", "url": "https://questionsmedicales.fr/author/Woody%20March-Steinman", "affiliation": { "@type": "Organization", "name": "Applied Mathematics, University of Arizona, Tucson, AZ, 85721." } }, { "@type": "Person", "name": "Lisa Shanks", "url": "https://questionsmedicales.fr/author/Lisa%20Shanks", "affiliation": { "@type": "Organization", "name": "Molecular and Cellular Biology, University of Arizona, Tucson, AZ, 85721." } }, { "@type": "Person", "name": "Vineet K Maurya", "url": "https://questionsmedicales.fr/author/Vineet%20K%20Maurya", "affiliation": { "@type": "Organization", "name": "Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Leveraging Implementation Science for Cardiovascular Health Equity: A Scientific Statement From the American Heart Association.", "datePublished": "2022-10-10", "url": "https://questionsmedicales.fr/article/36214131", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1161/CIR.0000000000001096" } }, { "@type": "ScholarlyArticle", "name": "Building implementation science capacity among practitioners of cancer control: development of a pilot training curriculum.", "datePublished": "2022-07-17", "url": "https://questionsmedicales.fr/article/35842850", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10552-022-01604-8" } }, { "@type": "ScholarlyArticle", "name": "Perspective: leveraging review protocols to advance implementation science in support of older adults' health equity.", "datePublished": "2024-10-11", "url": "https://questionsmedicales.fr/article/39463900", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2024.1457591" } }, { "@type": "ScholarlyArticle", "name": "Building CapaCITY/É for sustainable transportation: protocol for an implementation science research program in healthy cities.", "datePublished": "2024-04-17", "url": "https://questionsmedicales.fr/article/38631827", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2024-085850" } }, { "@type": "ScholarlyArticle", "name": "Implementation Science Fundamentals: Pediatric Surgery Enhanced Recovery After Surgery Protocol for Pectus Repair.", "datePublished": "2022-11-21", "url": "https://questionsmedicales.fr/article/36423481", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jss.2022.10.018" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Facteurs de transcription", "item": "https://questionsmedicales.fr/mesh/D014157" }, { "@type": "ListItem", "position": 5, "name": "Facteurs de transcription EGR", "item": "https://questionsmedicales.fr/mesh/D051765" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Facteurs de transcription EGR - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Facteurs de transcription EGR", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Facteurs de transcription EGR", "description": "Comment diagnostiquer une dysrégulation des EGR ?\nQuels tests sont utilisés pour évaluer les EGR ?\nLes EGR peuvent-ils être mesurés dans le sang ?\nQuels symptômes indiquent une anomalie des EGR ?\nLes EGR sont-ils impliqués dans des maladies spécifiques ?", "url": "https://questionsmedicales.fr/mesh/D051765?mesh_terms=Implementation+Science&page=7#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Facteurs de transcription EGR", "description": "Quels symptômes sont liés à une surproduction d'EGR ?\nLes EGR affectent-ils le système immunitaire ?\nQuels signes cliniques sont associés aux EGR ?\nLes EGR sont-ils liés à des troubles mentaux ?\nComment les EGR influencent-ils le développement embryonnaire ?", "url": "https://questionsmedicales.fr/mesh/D051765?mesh_terms=Implementation+Science&page=7#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Facteurs de transcription EGR", "description": "Peut-on prévenir les anomalies liées aux EGR ?\nLes facteurs environnementaux influencent-ils les EGR ?\nComment réduire le risque de dysrégulation des EGR ?\nL'exercice physique influence-t-il les EGR ?\nLes suppléments nutritionnels affectent-ils les EGR ?", "url": "https://questionsmedicales.fr/mesh/D051765?mesh_terms=Implementation+Science&page=7#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Facteurs de transcription EGR", "description": "Existe-t-il des traitements ciblant les EGR ?\nComment moduler l'activité des EGR ?\nLes EGR peuvent-ils être une cible pour le cancer ?\nQuels médicaments affectent les EGR ?\nLes EGR sont-ils impliqués dans la thérapie cellulaire ?", "url": "https://questionsmedicales.fr/mesh/D051765?mesh_terms=Implementation+Science&page=7#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Facteurs de transcription EGR", "description": "Quelles complications peuvent survenir avec des EGR anormaux ?\nLes EGR sont-ils liés à des maladies chroniques ?\nComment les EGR affectent-ils la santé cardiovasculaire ?\nLes EGR peuvent-ils causer des troubles neurologiques ?\nQuelles sont les conséquences d'une surproduction d'EGR ?", "url": "https://questionsmedicales.fr/mesh/D051765?mesh_terms=Implementation+Science&page=7#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Facteurs de transcription EGR", "description": "Quels facteurs augmentent le risque de dysrégulation des EGR ?\nLe stress influence-t-il les EGR ?\nL'alimentation joue-t-elle un rôle dans les EGR ?\nLes infections affectent-elles les EGR ?\nL'âge est-il un facteur de risque pour les EGR ?", "url": "https://questionsmedicales.fr/mesh/D051765?mesh_terms=Implementation+Science&page=7#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysrégulation des EGR ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des analyses d'expression génique peuvent être utilisés." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les EGR ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests PCR et les Western blot sont couramment utilisés pour évaluer l'expression des EGR." } }, { "@type": "Question", "name": "Les EGR peuvent-ils être mesurés dans le sang ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de tests sanguins standardisés pour mesurer les EGR." } }, { "@type": "Question", "name": "Quels symptômes indiquent une anomalie des EGR ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies de croissance ou des troubles neurologiques peuvent indiquer une dysrégulation." } }, { "@type": "Question", "name": "Les EGR sont-ils impliqués dans des maladies spécifiques ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont associés à des maladies comme le cancer et les troubles neurodégénératifs." } }, { "@type": "Question", "name": "Quels symptômes sont liés à une surproduction d'EGR ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Une surproduction peut entraîner une hyperplasie cellulaire et des troubles de croissance." } }, { "@type": "Question", "name": "Les EGR affectent-ils le système immunitaire ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils régulent la réponse immunitaire et peuvent influencer l'inflammation." } }, { "@type": "Question", "name": "Quels signes cliniques sont associés aux EGR ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme la fatigue, des douleurs musculaires et des troubles cognitifs peuvent apparaître." } }, { "@type": "Question", "name": "Les EGR sont-ils liés à des troubles mentaux ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des études montrent un lien potentiel entre les EGR et des troubles comme la dépression." } }, { "@type": "Question", "name": "Comment les EGR influencent-ils le développement embryonnaire ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Ils jouent un rôle crucial dans la régulation des gènes nécessaires au développement embryonnaire." } }, { "@type": "Question", "name": "Peut-on prévenir les anomalies liées aux EGR ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir certaines anomalies." } }, { "@type": "Question", "name": "Les facteurs environnementaux influencent-ils les EGR ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs comme le stress et la pollution peuvent affecter leur expression." } }, { "@type": "Question", "name": "Comment réduire le risque de dysrégulation des EGR ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les toxines et maintenir un bon équilibre hormonal peut réduire le risque." } }, { "@type": "Question", "name": "L'exercice physique influence-t-il les EGR ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut moduler l'expression des EGR et améliorer la santé globale." } }, { "@type": "Question", "name": "Les suppléments nutritionnels affectent-ils les EGR ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certains suppléments, comme les acides gras oméga-3, peuvent influencer leur expression." } }, { "@type": "Question", "name": "Existe-t-il des traitements ciblant les EGR ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies géniques et des inhibiteurs spécifiques sont en cours de recherche." } }, { "@type": "Question", "name": "Comment moduler l'activité des EGR ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des agents pharmacologiques et des modifications épigénétiques peuvent moduler leur activité." } }, { "@type": "Question", "name": "Les EGR peuvent-ils être une cible pour le cancer ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les EGR sont des cibles potentielles pour des traitements anticancéreux innovants." } }, { "@type": "Question", "name": "Quels médicaments affectent les EGR ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments anti-inflammatoires peuvent influencer l'expression des EGR." } }, { "@type": "Question", "name": "Les EGR sont-ils impliqués dans la thérapie cellulaire ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, leur régulation est essentielle pour le succès des thérapies cellulaires et régénératives." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des EGR anormaux ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme le cancer, les maladies auto-immunes et les troubles métaboliques peuvent survenir." } }, { "@type": "Question", "name": "Les EGR sont-ils liés à des maladies chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une dysrégulation des EGR est associée à des maladies chroniques comme le diabète." } }, { "@type": "Question", "name": "Comment les EGR affectent-ils la santé cardiovasculaire ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une régulation anormale des EGR peut contribuer à des maladies cardiovasculaires." } }, { "@type": "Question", "name": "Les EGR peuvent-ils causer des troubles neurologiques ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans l'expression des EGR sont liées à des troubles neurologiques." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une surproduction d'EGR ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une surproduction peut entraîner des tumeurs et des désordres de croissance cellulaire." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de dysrégulation des EGR ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme l'exposition à des toxines et des prédispositions génétiques augmentent le risque." } }, { "@type": "Question", "name": "Le stress influence-t-il les EGR ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter l'expression des EGR et la santé cellulaire." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle dans les EGR ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en antioxydants peut aider à réguler l'expression des EGR." } }, { "@type": "Question", "name": "Les infections affectent-elles les EGR ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections peuvent moduler l'expression des EGR, influençant la réponse immunitaire." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque pour les EGR ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut affecter l'expression des EGR et la régulation génétique." } } ] } ] }

Sources (10000 au total)

Building implementation science capacity among practitioners of cancer control: development of a pilot training curriculum.

Cancer control interventions are difficult to implement with fidelity, while tailoring to fit contexts. Engaged approaches are suggested to advance equity. On-the-ground practitioners are needed to se... The Cancer Control Implementation Science Base Camp (CCISBC) was created to improve capacity among cancer control practitioners when implementing evidence-based cancer screening programs in specific c... Nine competencies overlapped between four of the curricula scanned in this study, all of which served as the basis for learning objectives. Principles that emerged from design sessions included stayin... In order to scale practice-based evidence, practitioners will need to be engaged. This engagement is optimized when practitioners are trained to collaborate on implementation research. The CCISBC is a...

Building CapaCITY/É for sustainable transportation: protocol for an implementation science research program in healthy cities.

Improving sustainable transportation options will help cities tackle growing challenges related to population health, congestion, climate change and inequity. Interventions supporting active transport... Across nine Canadian municipalities and the State of Victoria (Australia), our research will focus on two types of sustainable transportation interventions: all ages and abilities bicycle networks and... This study received approval from the Simon Fraser University Office of Ethics Research (H22-03469). A Knowledge Mobilization Hub will coordinate dissemination of findings via a website; presentations...

Implementation Science Fundamentals: Pediatric Surgery Enhanced Recovery After Surgery Protocol for Pectus Repair.

Surgical repair of pectus excavatum and carinatum in children has historically been associated with severe postoperative pain and prolonged hospitalization. Enhanced Recovery After Surgery (ERAS) is a... A multidisciplinary team of providers worked collaboratively to develop an ERAS protocol for surgical repair of pectus excavatum and carinatum and methods for identifying eligible patients. The surgic... Our entire pediatric surgery team, nurses at every stage (clinic/preoperative/recovery/floor), physical therapy, and information technology contributed to the creation and implementation of an ERAS pr... This is one of the first studies in children which details the step-by-step process of developing and implementing an ERAS protocol for pectus excavatum and carinatum. The process of development and i...

Increasing clinician participation in tobacco cessation by an implementation science-based tobacco cessation champion program.

We designed a process to increase tobacco cessation in an academic center and its widely distributed network community sites using clinical champions to overcome referral barriers.... In 2020 a needs assessment was performed across the City of Hope Medical Center and its 32 community treatment sites. We reviewed information science strategies to choose elements for our expanded tob... Cancer center leadership committed to expanding tobacco control. Funding was obtained through a Cancer Center Cessation Initiative (C3I) grant. Multi-disciplinary leaders developed a comprehensive pla... An efficient process to expand smoking cessation in the City of Hope network was developed using implementation science strategies and cessation champions. This well-detailed implementation process ma...

Leveraging implementation science theories to develop and expand the use of a penicillin allergy de-labeling intervention.

Penicillin allergy is the most frequently reported drug allergy, yet most patients can tolerate the drug if challenged. Despite this discrepancy, large scale penicillin allergy de-labeling interventio... We followed a four-step process that leverages qualitative analysis to design evidence-based, actionable strategies to develop an intervention. First, we specified the clinician-perceived barriers to ... Evidence-based strategies such as focused education and training in penicillin allergy evaluation can address knowledge and confidence barriers reported by frontline clinicians. Other key strategies i... Empowering clinicians beyond allergy specialists to conduct penicillin allergy assessments requires designing new workflows and systems and providing additional knowledge to those clinicians....

Rapid start antiretroviral therapies for improved engagement in HIV care: implementation science evaluation protocol.

In 2020, the Health Resources and Services Administration's HIV/AIDS Bureau funded an initiative to promote implementation of rapid antiretroviral therapy initiation in 14 HIV treatment settings acros... The ETAP has used implementation science methods framed by the Dynamic Capabilities Model integrated with the Conceptual Model of Implementation Research to develop a Hybrid Type II, multi-site mixed-... This approach will allow us to understand in detail the processes that sites to implement and integrate rapid initiation of antiretroviral therapy as standard of care as a means of achieving equity in...

Implementation science in traditional, complementary and integrative medicine: An overview of experiences from China and the United States.

The introduction of traditional, complementary and integrative medicine (TCIM) services into health systems has been advocated by the World Health Organization, but there is a paucity of reviews synth... The aim of this study was to identify, describe and analyse publications on these two key TCIM policy issues via an overview from an implementation science perspective.... Publications describing international experiences of implementing TCIM services or evidence for TCIM practices were identified by searching MEDLINE, EMBASE and Global Health databases in November 2021... Sixty-three relevant publications were included in the analysis. Current experiences in China and the United Sates (US) reflect varying policy priorities at different stages of implementing TCIM servi... Policymakers managing different stages of TCIM implementation will benefit from the experiences of practitioners in the US and China. Multi-level implementation interventions launched in the US provid...